baber/WOPTO huggingface dataset:
Patent NZ-505586-A (NZ)
Title: Indole and cyclopenta(b)pyrrole derivatives and pharmaceuticals thereof; useful as antagonists of the CCR2 (MCP-1) receptor
Inventor: FAULL ALAN WELLINGTON
IPC: C07D209/42
Filed: 1999-02-02
Abstract: A pharmaceutical composition which comprises a compound of formula (I), its salt, ester or amide, which is an inhibitor of monocyte chemoattractant protein-1 (MCP-1), and a method of preparing a compound of formula (I), and wherein: A and B form an optionally substituted alkylene chain so as to form a ring with the carbon atoms to which they are attached; X is CH2 or SO2, R1 is an optionally substituted aryl or heteroaryl ring; R2 is a specified organic group such as carboxy; and R3 is hydrogen or a specified organic group; in combination with a pharmaceutically acceptable carrier.
Patent NZ-513919-A (NZ)
Title: Imaging and planning device for ligament graft placement
Inventor: SATI MARWAN
IPC: A61B90/10
Filed: 1999-03-17
Abstract: Device for realtime computerized in-situ planning and guidance of ligament graft placement comprising: A) two rigid reference bodies (4; 5) with at least three markers (6) each and screws (7) or pins to attach the reference bodies (4; 5) to the femur (8) respectively to the tibia (9); B) a pointer (10) with at least three markers (6); C) an endoscope (11); D) a computer (3); E) a position measurement device (14) connected to the computer (3) in order to determine the position of the markers (6); F) an X-ray source (1) that may be used pre-operatively or intra-operatively; G) an X-ray receiver (2) for gathering medical image data which is transferred to the computer (3) either directly in numerical format or by scanning the radiographic film into the computer (3); and H) an A-mode ultrasound device (13) which is connected to the computer (3) and provided with at least three markers (6).
Patent NZ-514367-A (NZ)
Title: Identification system
Inventor: ASHWIN TERRENCE KETIH
IPC: G06K19/07
Filed: 2000-03-01
Abstract: An electronic tag (10) is provided which includes processor means and transmitter circuitry (26). The processor means, which is typically a micro-controller (16), is programmed to provide a modulation control signal which includes unique identification data which at least identifies the tag (10) but may include further data. The transmitter circuitry (26) is connected to the processor means and to an antenna (29) for transmission of the unique identification data. The transmitter circuitry (26) is powered by the modulation control signal. Preferably, the transmitter circuitry (26) is exclusively powered by the modulation control signal of the processor means. The invention extends to a receiver (12) for receiving a transmission from the tag (10) and to a system including a plurality of receivers (12) and tags (10). The invention also extends to a method of communicating data from an electronic tag (10) which includes driving transmitter circuitry (26) of the tag with a modulation control signal which substantially powers the transmitter circuitry (26).
Patent NZ-517523-A (NZ)
Title: Orthotopic total artificial heart
Inventor: GIAMBRUNO MARONO JUAN MANUEL
IPC: A61M1/12
Filed: 2000-08-03
Abstract: An orthotopic total artificial heart for replacing the human heart is stated to consist in a new design for the two blood chambers which are assembled in an original space arrangement relationship between each other and between their inlet ports and outlet ports. This design is stated to be a significant improvement in the use of the space which is available within the interior mediastinum with respect to prior models, thereby providing the required anatomical fit.
Patent NZ-523106-A (NZ)
Title: Cyclopentanoindoles, compositions containing such compounds and methods of treatment
Inventor: LABELLE MARC
IPC: H04W52/14
Filed: 2001-07-23
Abstract: Disclosed are cyclopentanoindole compounds of formula I, wherein: R4 and R5 are independently H, F, CN, alkyl, ORa, or S(O)nalkyl, or R4 and R5 on the same carbon represent oxo, or R4 and R5 taken together form an optionally substituted 3- or 4-membered ring optionally containing a heteroatom, Ar is optionally substituted aryl or heteroaryl, X is C=O, SO2 or optionally substituted alkylene, Q is optionally substituted alkyl, or Q and R6 together form an optionally substituted 3- or 4-membered ring optionally containing a heteroatom selected from N, S and O, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of prostaglandin mediated diseases.
Patent NZ-523156-A (NZ)
Title: Clear aqueous solution with a low level of volatile organic compounds for cleaning surfaces with a shiny finish
Inventor: WAGERS KEVIN J
IPC: B08B3/08
Filed: 2001-06-15
Abstract: An all-purpose cleaner for hard surfaces comprises an aqueous solution of a secondary alcohol ethoxylate surfactant, an alkylpolyglycoside surfactant, and water, optionally comprising a chelating agent and a pH modification agent that provides an alkaline solution. The ethoxylate surfactants preferably have HLB values of from 12.2 to 14.6, and each surfactant may comprise up to about 5 weight percent of the solution. The solution may be free of organic solvents, such as alkylene glycol or alkylene glycol ethers, or other volatile organic compounds. As a result, the solution may be fragrance free, and, if so desired, colourless. Optionally, however, the cleaning solution may contain fragrances, colouring agents, anti-bacterials, stabilizers, preservatives, and other constituents, including a minor amount of a co-surfactant.
Patent NZ-524018-A (NZ)
Title: Use of 2alpha-methyl-19-nor-20(s)-1alpha,25-dihydroxyvitamin D3 to increase bone strength
Inventor: DELUCA HECTOR F
IPC: A61K31/59
Filed: 2001-07-10
Abstract: 2alpha-methyl-19-nor-20(S)-1alpha, 25-dihydroxyvitamin D3 can be used in the preparation of a medicament for bone replacement procedures for increasing the bone strength.
Patent NZ-525748-A (NZ)
Title: Wind Energy Turbine
Inventor: WOBBEN ALOYS
IPC: F03D3/00
Filed: 2001-09-08
Abstract: The invention relates to a wind energy turbine comprising a rotor with at least one rotor blade (10) and a displacement unit (12) for the rotor blade (10). An increase in the size of the turbine and consequently that of the rotor blades requires an increase in the size of the drives for the rotor blade displacement. This in turn requires a greater investment in logistical, temporal and material resources, especially if damage occurs. To avoid these disadvantages, the turbine is provided with a displacement device comprising more than one drive. Each drive thus produces a fraction of the power, allowing it to have smaller dimensions and impinges upon the components connected downstream to a corresponding lesser extent.
Patent NZ-529614-A (NZ)
Title: Prevention of addiction in pain management
Inventor: DEWEY STEPHEN L
IPC: A61P25/04
Filed: 2002-04-08
Abstract: Disclosed is the use of an opioid analgesic having addictive liability and gamma vinyl GABA in the manufacture of a medicament for treating a host for pain while decreasing the host's likelihood of addiction to the analgesic.
Patent NZ-531591-A (NZ)
Title: 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
Inventor: LOWE JOHN ADAMS
IPC: A61P25/14
Filed: 2002-09-24
Abstract: Disclosed herein are compounds namely: 6-[4-(N, N-dimethylaminomethyl)-5-ethyl-2-methoxy-phenyl]-pyridin-2-ylamine, 6-[4-(N-methylaminomethyl)-5-ethyl-2-methoxy-phenyl]-pyridin-2-ylamine and 6-[4-(3-azetidinoxy)-5-ethyl-2-methoxy-phenyl]-pyridin-2-ylamine, and the pharmaceutically acceptable salts thereof, pharmaceutical compositions containing such compounds and the use of such compounds as nitric oxide synthase inhibitors in the treatment and prevention of disorders of the central nervous system. Also described are compounds namely: 6-[4-(N-methyl-3-azetidinoxy)-5-ethyl-2-methoxy-phenyl]-pyridin-2-ylamine and 6-[4-(2-dimethylamino-ethoxy)-5-ethyl-2-methoxy-phenyl]-pyridin-2-ylamine.
Patent NZ-532003-A (NZ)
Title: Method of administering a reward scheme
Inventor: MANNERS EDWARD PRESTON
IPC: G06Q20/10
Filed: 2002-07-31
Abstract: A method of administering a rewards scheme comprises: receiving a plurality of Electronic Extract Reports (EERs) corresponding to a plurality of eligible transactions, each eligible transaction being a purchase transaction effected using an electronic transaction terminal between a business member of the rewards scheme and a customer member of the rewards scheme; identifying from the EERs the business member and customer member party to each eligible transaction and a cash amount associated with the eligible transaction; obtaining a credit from the business member for a predetermined percentage of the cash amount of each eligible transaction; providing a first portion of the credit to the customer member party to the eligible transaction for which the credit was obtained, and using a second portion of the credit to fund advertisement in favour of the business member.
Patent NZ-532903-A (NZ)
Title: Therapeutic use of a non-neurotoxic plasminogen activator from the saliva of Desmodus rotundus (DSPA) for the treatment of stroke.
Inventor: SOHNGEN MARIOLA
IPC: A61K38/00
Filed: 2002-10-31
Abstract: Described are the use and the production of non-neurotoxic plasminogen activating factors, derived, for example, from the common vampire Desmodus rotundus (DSPA), for therapeutic treatment of stroke in humans.
Patent NZ-536530-A (NZ)
Title: Apparatus and methods for running based training
Inventor: WOOD MATTHEW
Filed: 2004-11-11
Abstract: Apparatus and methods for running based training using resistance and assistance are disclosed. The apparatus (1) includes a cable retainer (2) that releases and collects a length of cable (3), the end of which is attached to a trainee (5). The cable provides a horizontal line of force from the trainee's centre of gravity (4) and can provide either resistance or assistance depending on whether the cable is being released or collected. A measuring device measure measures the length of cable released and collected over a set period of time
Patent NZ-537336-A (NZ)
Title: Method for operating a vending machine and vending system
Inventor: MAYER BORIS
Filed: 2003-08-07
Abstract: Disclosed is a vending machine system where the data for controlling multiple vending machines at separate locations is stored in a central data processing unit. The machines contain goods placed in storage compartments, and the goods can be removed by customers. The stored data can be used to trigger control commands that are transmitted to change the operating parameters of the vending machines. The parameters can include selling times, prices, offer contents, and specific offers for particular groups of customers.
Patent NZ-540003-A (NZ)
Title: Process for electrochemical oxidation of ferrocyanide to ferricyanide
Inventor: HORVATH ANDRAS
IPC: C07D491/10
Filed: 2003-09-19
Abstract: A process for oxidizing an aqueous phase comprising ferrocyanide (V) which is recovered from an oxidative phenolic coupling reaction, to an aqueous phase comprising ferricyanide (IV), in a divided electrochemical cell is disclosed, wherein the process comprises: preparing an anolyte comprising pretreating the aqueous phase comprising ferrocyanide (V) which is recovered from an oxidative phenolic coupling reaction by decantation or extraction or filtration; placing the anolyte in contact with an anodic electrode of the divided electrochemical cell; placing a catholyte in contact with a cathodic electrode of the divided electrochemical cell; and applying electrical power to the divided electrochemical cell, wherein the electrical power has an amperage or voltage and wherein the applying is for a time period sufficient to oxidize the ferrocyanide (V) to ferricyanide (IV).
Patent NZ-541848-A (NZ)
Title: Method of evaluating beef taste, texture and so on based on stearoyl-CoA desaturase genotype
Inventor: TSUJI SOICHI
IPC: C12N15/11
Filed: 2004-02-17
Abstract: A method for evaluating the amount of the unsaturated fatty acid content in beef fat on the basis of a genotype of bovine stearoyl-CoA desaturase to evaluate whether it is cattle from which good quality beef with good taste and texture can be produced is described. The method comprises determining the single nuclear polymorphisms (SNP) found in the gene of SEQ ID NO:1 present at position 878 and at positions 702, 762, 878, 1905, 3143, 3351, 3537 and/or 4736.
Patent NZ-544421-A (NZ)
Title: Sealed container for cooking rice in a microwave oven in a predetermined water/rice ratio
Inventor: MORI TOSHIKO
Filed: 2001-09-07
Abstract: Containers 30 for cooking water and rice in specific ratios are disclosed. The containers 30 include markings 34 that indicate the level to which the container should be filled with water for cooking a corresponding number of cups of rice. Different embodiments suitable for different types of rice have markings for optimal rice/water ratios depending on the type of rice. The container is sealed in a way that prevents egress of water vapour in order to maintain the rice/water ratio within the container.
Patent NZ-545060-A (NZ)
Title: Watertight joint comprising a lockseam and gasket material
Inventor: WALLACE NEIL EDWIN
IPC: B65D90/02
Filed: 2004-07-09
Abstract: A article (10) formed at least partially from at least one metal sheet incorporates at least one lockseam (20) that interconnects adjacent edge margins (18 and 19) of the sheet 17. The lockseam (20) includes a region where the edges overlap and wherein at least one of the edge margins has a coating (23) applied to it that is disposed in the overlap and forms a gasket to provide a watertight at the lockseam. A method of forming the lockseam is also disclosed.
Patent NZ-547210-A (NZ)
Title: Flour composition with increased total dietary fiber, process of making, and uses thereof
Inventor: OKONIEWSKA MONIKA K
IPC: A23L7/152
Filed: 2006-05-16
Abstract: Disclosed is a process of increasing the total dietary fibre of a flour comprising heating the flour under the conditions of a moisture content of between from 10 to 50% by weight of the flour, at a target temperature of from 80 to 160 degrees C, and a time of 0.5 to 15 minutes at the target temperature to produce a hydrothermally heated flour; wherein the flour has an amylose content of at least 40% by weight of starch in the flour or, if wheat or rice flour an amylose content of at least 27% by weight of starch in the flour; wherein the conditions are chosen to increase the total dietary fibre by at least 10% based on the weight of the flour.
Patent NZ-554283-A (NZ)
Title: Improvements in and relating to rapidly controlling room air temperature
Inventor: WORMALD BARRY P
IPC: F24F1/0038
Filed: 2007-04-03
Abstract: A method of rapidly controlling room temperature is disclosed. The method includes the steps of: (a) providing primary heating and cooling means which is, or includes, a radiant ceiling coil (24) in or on a ceiling of a room (10), and (b) providing secondary heating and cooling means which is, or includes, supplementary air (SA) which is discharged into the room (10), where the supplementary air (SA) is, or includes, forced air (FA) from a forced air supply external of the room (10). The supplementary air (SA) is selectively pre-heated or pre-cooled to accelerate a heating or cooling effect of the primary heating and cooling means.
Patent NZ-555504-A (NZ)
Title: Electret enhanced automatic IV drip chamber shutoff
Inventor: BROWN HOUSTON
IPC: A61M5/40
Filed: 2005-12-09
Abstract: An automatic shut off valve for use in regulating the flow of medical fluid from a medical fluid reservoir, comprises a container (38) configured to operate in an upright position and to contain a varying level of medical fluid received from the medical fluid source and an amount of air above the received medical fluid. The container has an upstream end, a downstream end disposed below the upstream end, and an exit orifice formed at the downstream end through which the medical fluid exits the container, the upstream end and the exit orifice configured so that the received medical fluid will fill the container to a normal operating fluid level during the time that the medical fluid source contains medical fluid, and further configured so that the medical fluid in the container will decrease below the normal operating level during the time that the medical fluid source contains no further medical fluid. An automatic shut off valve further comprises a valve seat (54) disposed adjacent the exit orifice at the downstream end of the container and formed of a non-magnetic and dielectric material; and a stop member (50) disposed and freely movable within the container having a buoyancy with which the stop member floats at the surface of the medical fluid in the container. The stop member is spaced apart from the valve seat when the medical fluid in the container has the normal operating level. The stop member is formed of a non-magnetic and dielectric material. At least one of the stop member and the valve seat comprises an electrical charge creating an electric field that attracts the other of the stop member and the valve seat and tends to move the stop member into sealing engagement with the valve seat to seal against fluid flow through the exit orifice. The electric field has a strength selected such that, when the medical fluid in the container reaches a selected level that is more than empty but less than the normal operating level the electric field overcomes the buoyancy of the stop member to move the stop member into sealing engagement with the valve seat, thereby preventing air above the medical fluid from flowing through the exit orifice.
Patent NZ-563509-A (NZ)
Title: Mutated Fc monoclonal antibodies specific to C5, C5 convertase, C5a or C5b-9 which do not activate complement cascade for use in treatment of pulmonary conditions
Inventor: WANG YI
IPC: A61K39/395
Filed: 2006-05-10
Abstract: Discloses the use of an antibody that inhibits activation of the complement cascade in the manufacture of a medicament for preventing or treating a pulmonary condition in a subject, wherein said antibody has an active Fab fragment and a mutated Fc portion, wherein the mutated Fc portion does not activate complement, wherein the medicament is suitable for co-administration with an additional active agent, and wherein said antibody is specific to C5, C5 convertase, C5a or C5b-9. Further disclosed is the use of an additional active agent, and pulmonary drug delivery kits comprising said antibody which are formulated for inhalation delivery.
Patent NZ-566001-A (NZ)
Title: Conformable solvent-based bandage and coating material
Inventor: SALAMONE ANN BEAL
IPC: A61K31/785
Filed: 2006-08-17
Abstract: Disclosed is a liquid coating material comprising about 0.5 to about 50 wt percent polymerizable cyanoacrylate monomer and about 10 to about 99.9 wt percent of a volatile liquid selected from the group consisting of volatile linear and cyclic siloxanes, volatile polydimethylsiloxanes, isooctane, octane, and combinations thereof, said volatile liquid being present in an amount such that the liquid coating material does not adhere to a second glass surface, when: (i) the liquid coating material is applied to a first glass surface, and (ii) the second glass surface is applied to the first glass surface, having the liquid coating material disposed there between, said coating material forming an adherent, conformable polymer coating when applied to a surface. Also disclosed is a kit comprising said liquid coating material.
Patent NZ-566367-A (NZ)
Title: N-Aryl diazaspiracyclic compounds capable of affecting nicotinic cholinergic receptors and methods of preparation and use thereof
Inventor: MILLER CRAIG H
IPC: C07D453/00
Filed: 2003-06-27
Abstract: Certain compounds of formula (I) are disclosed. The compounds can be used to treat and/or prevent disorders characterized by dysfunction of nicotinic choligernic neurotransmission, including disorders involving neuromodulation of neurotransmitter release, such as dopamine release. Central nervous system disorders, which are characterized by an alteration in normal neurotransmitter release, are another example of disorders that can be treated and/or prevented. The compounds and compositions can also be used to alleviate pain.
Patent NZ-567273-A (NZ)
Title: Two-part code
Inventor: PINCHEN STEPHEN PAUL
IPC: G06K19/06
Filed: 2006-10-03
Abstract: A code system for associating data with articles and a method of verifying the authenticity or lack of authenticity of a graphically representable machine readable code are disclosed. The system comprises means for generating graphic codes for application to articles, machine means for reading the codes to convert each code into a string of characters, and storage means arranged to store data associated with each code. The codes each comprise a first part that carries no information at the time of its creation and a second part. The system includes a population N of codes having, within the population, unique first parts, and within the system a population n of the codes has unique second parts, N > n, and for each code the first part and the second part are related, and a number N/n of codes share the same second parts but have unique first parts. The method comprising machine-reading both the first part and the second part of the code and determining whether the two parts of the code are related, and verifying that the code is authentic in the event that the two parts are related, and verifying that the code is not authentic in the event that the two parts are not related.
Patent NZ-568394-A (NZ)
Title: Process for manufacturing chewable dosage forms for drug delivery and products thereof
Inventor: PAULSEN NEIL E
IPC: A61K47/00
Filed: 2006-12-05
Abstract: To manufacture a soft chewable medicine the active ingredient and dry inactive ingredients are provided to a horizontally disposed mixing chamber and blended together by rotation of a mixing shaft within the chamber to cast the ingredients in a pattern away from and between the walls of the mixing chamber space until a dry mixture is formed. A softening agent is added to and blended with the dry mixture to form a soft chewable mixture that is then formed into individual masses of consistent weight. No heat is applied to either the dry or blended chewable mixture during the mixing or forming steps. The process provides stable concentrations of the active ingredient, and produces chews of consistent weight and texture.
Patent NZ-568562-A (NZ)
Title: Preparation of vaccine master cell lines using recombinant plant suspension cultures
Inventor: MIHALIAK CHARLES A
IPC: A61K39/00
Filed: 2006-10-23
Abstract: Disclosed is a plant cell culture for producing proteinaceous vaccine antigen comprising: a) a NT-l cell stably transformed to express a transgene encoding a proteinaceous vaccine antigen comprising SEQ ID NO:2; and b) a growth medium which supports the growth of said NT-1 cell in culture but which does not support the growth of Mycoplasmataceae and contains no materials of animal origin, said growth medium comprising no materials of animal origin and NT-1 liquid medium, wherein said NT-1 cell is capable of being continuously passaged such that consistent transgene expression is maintained during passaging and wherein said NT-1 cell is capable of being cryopreserved such that consistent transgene expression is recovered upon recovery from cryopreservation.